Tag Archives: JSE research

ARB Holdings – H1:20 – Lean & Efficient

Share Code: ARH – Market Cap: R0.9bn – PE: 5.9x – DY: 6.3%

H1:20 – Great cost-control despite headwinds

  • While ARB missed out topline expectations, management’s extraction of efficiencies across the Group saw a resilient profit performance.
  • The disappointments were all in sales, as Eskom/contractor volumes remained weak in the Electrical Division and retailer/consumer markets stagnated.
  • The victories were all won in costs as the Radiant acquisition begins to bed-down, an underperforming Electrical store was closed and the Lord’s View DC began operations.
  • Slight “pre-Chinese New Year” overstocking across the Group negatively impacted on cash flows but should serve the Group well given the current Covid-19 (i.e. “Coronavirus”) disruption to global supply chains and the coming likely stock shortages across global and domestic markets.

Our Thoughts: H2 to remain tough, but long-term positive

  • The Group remains ungeared, has positive cost-savings that should annualize nicely going forward and is well-positioned to weather the current macro-headwinds and capture any growth that may appear going forward.
  • Unfortunately, H2 in South Africa and with growing global risks is likely to remain a tight trading environment and one with a lot of forecast risk (either upside or downside).

Forecast, Valuation & Implied Return: Still underrated

  • Our fair value for ARH is 562cps (previously: 576cps) on an implied Price Earnings (PE) of 8.3x, indicating that the stock is c.39% undervalued at its current share price.
  • Rolling our fair value forward at our CoE, we arrive at a 12m TP of 659cps (previous 12m TP: 670cps) on an Exit PE of 13.2x.
  • Key risks to the Group are unchanged from our Initiation of Coverage.

About Blue Gem Research (Pty) Ltd

Blue Gem Research is built upon the belief that we can make the market work better.

A structural bottleneck in the South African equity market is the reality that sell-side analysts are incentivized via allocation, trade volumes and related brokerage to cover large, liquid stocks. While this can add value to the market, the law of marginal diminishing returns implies that it adds less and less value as more and more analysts cover the same finite number of stocks (i.e. the Top 40 index on the JSE).

Even the few analysts covering stocks outside this Top 40 index are incentivized to cover the more liquid counters in this universe in order to effectively monetize their research.

The irony is that the very stocks that would benefit the most from being professionally researched are the very stocks that are also marginalized by these sell-side economics: the dynamic, growing, exciting small cap counters that do not feature on this radar due to size, illiquidity or both.

And so Blue Gem Research was founded to address this critical need in the local market and, by doing so, make our market work better for all participants.

The logic is simple. Research on the under-covered small caps cannot be economically monetized by brokerage. But the benefit of professional coverage is felt directly by the small cap itself. Hence we charge the company being covered directly for its coverage and provide the research to the rest of the market for free.

We need to be clear, Blue Gem Research produces commissioned research. But, let us also be clear, all research is indirectly paid for by one or more parties. We are merely being transparent about this fact on this website and in our research disclosures.

Offering the market selective commissioned research of small caps solves numerous challenges:

  1. Investors and the general market can benefit from freely available professional research on these under-covered stocks (you do not need to agree with every word or conclusion in a research note to take value from the work done and presented in it),
  2. The small caps can feel the benefit of professional coverage from added exposure in both the investment community and the general public, and
  3. The research is sufficiently monetized to justify the time, effort and expense of building and maintaining it (it has taken nearly two decades of experience and significant amounts of time to build an individual note).

Essentially, this is Blue Gem Research’s rationale: balancing the risk of commissioned research against the vast potential value-add to the broader market and individual stocks we have chosen to cover.

If you are new to reading professional research reports, some terms and abbreviations may be new to you. Please see our Frequently Asked Questions page we answer some of the most common questions thrown at us regarding Blue Gem Research.

Finally, see our Disclaimer page discloses some of the finer legal details of our research. While it may be a boring read, it is quite important that you understand our global disclaimer. By browsing this website and its research (even if you received it in your inbox or via social media), you are assumed to have read, understood and agreed to this disclaimer.

Note: Blue Gem Research can be followed on Twitter and liked on Facebook. We also strongly suggest subscribing to Blue Gem Research by entering your email address into the box below in order to get email updates the moment we publish anything new.

Enter your email to subscribe for Blue Gem Research:

Thank you for all your support in our attempt to make the market work better!

Kind regards,

Keith McLachlan